Who is K. Alice Leung?
Leung joined Intarcia Therapeutics as President and CEO in March 2004.
Prior to joining Intarcia, she was Vice President, General Manager of
the Oncology business unit for Berlex Laboratories, the US affiliate of
Schering AG. In addition, she managed the emerging gastroenterology
business for Berlex Laboratories, and was the site executive for the
company's Puget Sound site, where the commercial biological
manufacturing function for Schering AG is located. Her previous
experience includes a 15-year tenure at Bristol-Myers Squibb, where she
was in various marketing, sales, manufacturing, business development
and licensing functions of increasing responsibility. She managed the
growth of some of the world's leading oncology treatments, and was
responsible for licensing activities across all therapeutic areas
within the pharmaceutical portfolio of BMS. In her last role there as
Vice President, Worldwide Licensing and External Development, she was a
member of the Institute Executive Committee of the Pharmaceutical
Research Institute of BMS and participated in the strategy, portfolio
planning and policy development for the RD functions in addition
to her functional role. Ms. Leung is a graduate of the University of
Western Ontario, in London, Ontario, Canada, and received her MBA from
the Johnson School of Management, Cornell University.
Use the citation below to add to a bibliography:
We need you!
Help us build the largest biographies collection on the web!